Lead Cell Therapy Candidate

About Moonlight Bio

Moonlight Bio is a private, preclinical-stage biotech focused on developing next-generation T cell therapies for cancer by mining evolutionary biology. The company leverages a discovery platform that identifies naturally occurring, potent T cell adaptations within human biology to engineer enhanced cell therapies, primarily targeting solid tumors. Key strategic partnerships with MaxCyte, Kincell Bio, and ZenQMS in 2025-2026 indicate active platform and pipeline advancement. As a young, pre-revenue company, its success hinges on translating its novel evolutionary insights into clinically differentiated and effective therapies.

Therapeutic Areas

Other Solid Tumors (Oncology) Drugs